Stonegate Investment Group, LLC Charles River Laboratories International, Inc. Transaction History

Stonegate Investment Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$206.39 - $268.73 $5,366 - $6,986	26 Added 2.66%	1,002 $206,000
Q1 2024 Apr 22, 2024	BUY	$203.52 - $273.43 $198,635 - $266,867	976 New	976 $264,000
Q3 2023 Oct 24, 2023	SELL	$194.44 - $217.61 $27,416 - $30,683	-141 Reduced 12.09%	1,025 $200,000
Q2 2023 Jul 26, 2023	BUY	$183.71 - $210.25 $11,206 - $12,825	61 Added 5.52%	1,166 $245,000
Q1 2023 Apr 20, 2023	BUY	$191.89 - $259.92 $16,310 - $22,093	85 Added 8.33%	1,105 $223,000
Q4 2022 Jan 24, 2023	SELL	$197.11 - $250.07 $17,345 - $22,006	-88 Reduced 7.94%	1,020 $0
Q3 2022 Oct 28, 2022	BUY	$182.44 - $250.54 $20,433 - $28,060	112 Added 11.24%	1,108 $218,000
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $17,759 - $26,308	87 Added 9.57%	996 $213,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $62,344 - $88,354	244 Added 36.69%	909 $258,000
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $233,667 - $298,372	665 New	665 $251,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonegate Investment Group, LLC with notifications on news.